STERIS plc confirmed earnings guidance for the fiscal year 2024. For the year the company expected revenue growth of 9% to 10% and constant currency organic revenue growth of 6% to 7%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
231.3 USD | +2.36% | +11.31% | +5.22% |
02:18pm | Wolfe Research Adjusts Price Target on STERIS to $240 From $235 | MT |
01:22pm | Piper Sandler Adjusts Price Target on STERIS to $225 From $220 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.22% | 22.33B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- STE Stock
- News STERIS plc
- STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024